GENG Le-le,HUANG Hui,XUAN Yi-chen,et al.Hunyuan moxibustion for diarrhea-predominant irritable bowel syndrome of spleen and kidney yang deficiency: a randomized controlled trial[J].Chinese Acupuncture & Moxibustion,2023,43(09):1028-1032.
GENG Le-le,HUANG Hui,XUAN Yi-chen,et al.Hunyuan moxibustion for diarrhea-predominant irritable bowel syndrome of spleen and kidney yang deficiency: a randomized controlled trial[J].Chinese Acupuncture & Moxibustion,2023,43(09):1028-1032.DOI: 10.13703/j.0255-2930.20220219-k0001.
Hunyuan moxibustion for diarrhea-predominant irritable bowel syndrome of spleen and kidney yang deficiency: a randomized controlled trial
moxibustion and oral western medication on diarrhea-predominant irritable bowel syndrome(IBS-D)of spleen and kidney
yang
deficiency.
Methods
2
Sixty patients with IBS
-D of spleen and kidney
yang
deficiency were randomly divided into a Hunyuan moxibustion group and a western medication group
30 cases each group. The Hunyuan moxibustion group was treated with
Hunyuan
moxibustion at Guanyuan(CV 4),40 min each time
once a day; in the western medication group,loperamide hydrochloride capsules (2 mg each time
3 times a day) and bacillus licheniformis live capsules (0.5 g each time
3 times a day) were given orally.Both groups were treated for 20 days. The scores of irritable bowel syndrome(IBS)symptom severity scale(IBS-SSS)
IBS quality of life scale (IBS-QOL) and TCM symptom grading quantitative were observed before and after treatment
and the clinical efficacy and safety were evaluated in the two groups.
Results
2
After treatment,each item scores and total scores of IBS-SSS in the two groups were lower than those before treatment(
P
<
0.05)
and the total scores of IBS-QOL were higher than those before treatment (
P
<
0.05);each item score and total score of IBS-SSS in the Hunyuan moxibustion group were lower than those in the western medication group (
P
<
0.05)
and the total score of IBS-QOL in the Hunyuan moxibustion group was higher than that in the western medication group (
P
<
0.05).After treatment
each item score and total score of TCM symptom grading quantitative in the Hunyuan moxibustion group were lower than those before treatment (
P
<
0.05)
the abdominal pain
diarrhea
lack of appetite scores and total score in the western medication group were lower than those before treatment (
P
<
0.05);and the abdominal pain
soreness and weakness of waist and knees
fear to cold and cold limbs scores and total score in the Hunyuan moxibustion group were lower than those in the western medication group (
P
<
0.05).The total effective rate was 90.0%(27/30)in the Hunyuan moxibustion group
whi
ch was higher than 73.3%(22/30)in the western medication group (
P
<
0.05). No adverse reactions occurred in both groups during treatment.
Conclusion
2
Hunyuan
moxibustion can effectively improve the symptom severity and quality of life in patients with IBS-D of spleen and kidney
yang
deficiency
especially in improving the symptoms of abdominal pain
soreness and weakness of waist and knees
fear to cold and cold limbs.Its therapeutic effect is superior to western medication.
关键词
Keywords
references
Hillestad EMR , van der Meeren A , Nagaraja BH , et al . Gut bless you: the microbiota-gut-brain axis in irritable bowel syndrome [J ] . World J Gastroenterol , 2022 , 28 ( 4 ): 412 - 431 .
Sperber AD , Bangdiwala SI , Drossman DA , et al . Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study [J ] . Gastroenterology , 2021 , 160 ( 1 ): 99 - 114.e3 .
Ballou S , Katon J , Rangan V , et al . Brief behavioral therapy for insomnia in patients with irritable bowel syndrome: a pilot study [J ] . Dig Dis Sci , 2020 , 65 ( 11 ): 3260 - 3270 .
Norlin AK , Walter S , Icenhour A , et al . Fatigue in irritable bowel syndrome is associated with plasma levels of TNF-α and mesocorticolimbic connectivity [J ] . Brain Behav Immun , 2021 , 92 : 211 - 222 .
Guo QQ , Lin H , Chen PC , et al . Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules [J ] . Bioengineered , 2021 , 12 ( 2 ): 11885 - 11897 .
Altomare A , di Rosa C , Imperia E , et al . Diarrhea predominant-irritable bowel syndrome (IBS-D): effects of different nutritional patterns on intestinal dysbiosis and symptoms [J ] . Nutrients , 2021 , 13 ( 5 ): 1506 .
Betz C , Mannsdörfer K , Bischoff SC . Validation of the IBS-SSS [J ] . Z Gastroenterol , 2013 , 51 ( 10 ): 1171 - 1176 .
Torkzadeh F , Danesh M , Mirbagher L , et al . Relations between coping skills, symptom severity, psychological symptoms, and quality of life in patients with irritable bowel syndrome [J ] . Int J Prev Med , 2019 , 10 : 72 .
Fajrin FA , Nugroho AE , Susilowati R , et al . Molecular docking analysis of ginger active compound on transient receptor potential cation channel subfamily V member 1 (TRPV 1 ) [J ] . Indones J Chem , 2018 , 18 ( 1 ): 179 .
Ford AC , Sperber AD , Corsetti M , et al . Irritable bowel syndrome [J ] . Lancet , 2020 , 396 ( 10263 ): 1675 - 1688 .
Camilleri M . Management options for irritable bowel syndrome [J ] . Mayo Clin Proc , 2018 , 93 ( 12 ): 1858 - 1872 .
Colomier E , Algera J , Melchior C . Pharmacological therapies and their clinical targets in irritable bowel syndrome with diarrhea [J ] . Front Pharmacol , 2020 , 11 : 629026 .